Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 30,421 MXCT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | MAXCYTE, INC. (MXCT) | Grant/Award | 30,421 | n/a |
| Jun 12, 2026 | BioAge Labs, Inc. (BIOA) | Grant/Award | 22,000 | n/a |
| Jun 5, 2026 | LB PHARMACEUTICALS INC (LBRX) | Grant/Award | 10,000 | n/a |
| Jan 21, 2026 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 40,400 | n/a |
| Sep 12, 2025 | LB PHARMACEUTICALS INC (LBRX) | Grant/Award | 22,449 | n/a |
| Aug 27, 2025 | MAXCYTE, INC. (MXCT) | Sale | 10,684 | $22.4K |
| Jun 23, 2025 | MAXCYTE, INC. (MXCT) | Grant/Award | 29,210 | n/a |
| Jun 9, 2025 | BioAge Labs, Inc. (BIOA) | Grant/Award | 22,000 | n/a |
| Jan 23, 2025 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 40,400 | n/a |
| Dec 4, 2024 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Purchase | 30,000 | $46.4K |